Trial intelligence / Profile preview

Hemodynamic safety of isobaric levobupivacaine versus isobaric bupivacaine for spinal anesthesia in older hip fracture patients

2025-520970-21-00Phase 4Completed

Sponsor
Instituto de Investigación Sanitaria Hospital Clínico San Carlos
Start
Feb 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of levobupivacaine and bupivacaine in hip fracture (2 arms), sponsored by Instituto de Investigación Sanitaria Hospital Clínico San Carlos. Primary endpoint: Primary hemodynamic and oxygenation parameters. Started Feb 2025; status: completed.

02

Drugs

levobupivacainebupivacaine
03

Conditions

hip fracture

Beyond the preview

Go deeper on 2025-520970-21-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2025-520970-21-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call